Stocks to Watch: Top Performing Penny Stocks on Thursday Stocks to Watch: Top Performing Penny Stocks on Thursday Yogesh Supekar / Thursday, August 12, 2021 0 850 Article rating: 4.0 The rising covid cases in the Asian countries is one of the biggest concerns for the markets. Read more
High momentum stocks for todays trade: Price and volume busters! High momentum stocks for todays trade: Price and volume busters! Karan Dsij / Thursday, August 12, 2021 0 989 Article rating: 3.5 It’s important to note that we are still in the initial part of the trading session and there are as many as 22 stocks on NSE Exchange, which meets this criterion. Keep a watch on these stocks. Read more
Indoco Remedies jumps 17 per cent to hit all-time high; heres what fuelled the rally! Indoco Remedies jumps 17 per cent to hit all-time high; heres what fuelled the rally! Karan Dsij / Thursday, August 12, 2021 0 1044 Article rating: 3.9 The company launched two new products during the quarter in the domestic market. Meanwhile, EPS for the quarter stood at Rs 4.3. Read more
MF Risk Measures: When Less Is More MF Risk Measures: When Less Is More The next time that you select a fund, remember that less risk not only means less pain but more gain also. The article explains the how and why of this theory Ninad Ramdasi / Thursday, August 12, 2021 0 756 Article rating: 4.8 The next time that you select a fund, remember that less risk not only means less pain but more gain also. The article explains the how and why of this theory Read more
Cipla receives final approval for its abbreviated new drug application Cipla receives final approval for its abbreviated new drug application Cipla’s Difluprednate Ophthalmic Emulsion 0.05 per cent is an AB-rated generic therapeutic equivalent version of Novartis Pharmaceutical Corporation’s Durezol®. Armaan Madhani / Thursday, August 12, 2021 0 936 Article rating: 3.6 Pharmaceutical major Cipla has received final approval for generic version of Novartis Pharmaceuticals Corporation Durezol® (Difluprednate Ophthalmic Emulsion 0.05 per cent) from United States Food & Drug Administration (US FDA). Read more